Skip to content

Application and evaluation of drug-eluting beads in interventional therapy of liver metastasis in colorectal cancer

Application and evaluation of drug-eluting beads in interventional therapy of liver metastasis in colorectal cancer

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR1800017919
Enrollment
Unknown
Registered
2018-08-22
Start date
2018-09-03
Completion date
Unknown
Last updated
2018-08-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

liver metastasis in coloretcal cancer

Interventions

control group:chemotherapy

Sponsors

Shandong Institute of Cancer Prevention and Treatment
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 75 Years

Inclusion criteria

Inclusion criteria: 1) aged 18-75 years male and female; 2) patients with postoperative liver metastasis of colorectal cancer were diagnosed by pathology or clinic, and the primary lesion was removed; 3) no recurrence in situ and no other organ metastasis; 4) surgical resection, radiofrequency/microwave ablation and other treatments were rejected; 5) good liver function (child-pugh A or grade B); 6) no severe cardiopulmonary and kidney dysfunction; 7) fully understand and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1) other organ metastases besides liver; 2) have had or are currently developing other malignant tumors; 3) obvious arteriovenous fistula; 4) white blood cell count is 5 times, and creatinine > is 200umol/l; 7) have bleeding diseases or coagulation disorders, or are undergoing anticoagulation treatment; 8) have a history of major diseases involving the heart, lung, kidney, bone marrow or the central nervous system.

Design outcomes

Primary

MeasureTime frame
PFS;

Countries

China

Contacts

Public ContactJianjun Han

Shandong Institute of Cancer Prevention and Treatment

handoctor@163.com+86 0531-6762683

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026